14th March
TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.
10th November
Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...
TriviumVet announce collaboration with the Dog Aging Project
16th April
TriviumVet, today announced an exciting research collaboration with the Dog Aging Project, TRIAD Trial. What is the Dog Aging Project? The Dog Aging Project is an innovative...
TriviumVet announce publication of recent research into gastric acid suppression in dogs
11th March
TriviumVet are delighted to announce the publication of a clinical study assessing our first product in development, a gastric acid suppressant to treat gastric ulceration in dogs.
TriviumVet advance their first feline product, a potential treatment for HCM in cats
21st January
TriviumVet commence clinical study of first-in-disease treatment for HCM in cats We are delighted to announce the initiation of a ground-breaking clinical study in client-owned...
TriviumVet become sponsor of the fourth annual Feather In Her Cap Awards
14th January
TriviumVet become sponsor of the fourth annual Feather In Her Cap Awards TriviumVet are proud to announce that we have become a sponsor of the fourth annual Feather In Her Cap...
TriviumVet named in Ireland’s top 100 Start Ups List for the second year running
17th November
TriviumVet are delighted to be featured in Ireland’s premier list of the top 100 start ups in Ireland. Each year The Sunday Business Post profile the most exciting new companies...
TriviumVet raise €5million in funding to invest in exciting animal drug pipeline
20th May
“I think the sky is the limit, and ultimately that is the real adrenalin in business.” Serial entrepreneurs Louise Grubb and Tom Brennan want to build a portfolio of veterinary...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...
TriviumVet announce collaboration with the Dog Aging Project
16th April
TriviumVet, today announced an exciting research collaboration with the Dog Aging Project, TRIAD Trial. What is the Dog Aging Project? The Dog Aging Project is an innovative...
TriviumVet announce publication of recent research into gastric acid suppression in dogs
11th March
TriviumVet are delighted to announce the publication of a clinical study assessing our first product in development, a gastric acid suppressant to treat gastric ulceration in dogs.
TriviumVet advance their first feline product, a potential treatment for HCM in cats
21st January
TriviumVet commence clinical study of first-in-disease treatment for HCM in cats We are delighted to announce the initiation of a ground-breaking clinical study in client-owned...
TriviumVet become sponsor of the fourth annual Feather In Her Cap Awards
14th January
TriviumVet become sponsor of the fourth annual Feather In Her Cap Awards TriviumVet are proud to announce that we have become a sponsor of the fourth annual Feather In Her Cap...
TriviumVet named in Ireland’s top 100 Start Ups List for the second year running
17th November
TriviumVet are delighted to be featured in Ireland’s premier list of the top 100 start ups in Ireland. Each year The Sunday Business Post profile the most exciting new companies...
TriviumVet raise €5million in funding to invest in exciting animal drug pipeline
20th May
“I think the sky is the limit, and ultimately that is the real adrenalin in business.” Serial entrepreneurs Louise Grubb and Tom Brennan want to build a portfolio of veterinary...